August 5, 2025
Cellectis Reports Second Quarter 2025 Financial Results & Business Updates
Cellectis to host an Investor R&D Day in New York City on October 16, 2025: Phase 1 dataset and late-stage…
Pharmaceuticals, Biotechnology and Life Sciences
Cellectis to host an Investor R&D Day in New York City on October 16, 2025: Phase 1 dataset and late-stage…
HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the…
-CASGEVY® momentum building; >75 authorized treatment centers (ATCs) activated globally, achieving the target goal and ~115 patients have had cells…
Edward Conner, M.D. appointed Chief Medical Officer and John Bishop, Ph.D. appointed Chief Technical Operations Officer Justin Renz, Chief Financial…
RADNOR, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing…
Half-year financial report 2025Regulated information 2 August 2025 The board of directors of Financière de Tubize has established the 2025…
DALLAS, Aug. 01, 2025 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology…
VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (“Sirona”) wishes to provide…
LA JOLLA, Calif., July 31, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
REDWOOD CITY, Calif., July 31, 2025 (GLOBE NEWSWIRE) — Coherus Oncology, Inc. (Coherus, Coherus Oncology or the Company, Nasdaq: CHRS), today…